Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ü¿ÜÃæ°ÝÆļ⼮¼úÈÄ ±Þ¼º ½Å¼¼´¢°ü ¼Õ»ó¿¡ °üÇÑ ¿¬±¸ A Trying to Evaluate Acute Renal Tubular Damage after ESWL

´ëÇѺñ´¢±â°úÇÐȸÁö 1993³â 34±Ç 3È£ p.482 ~ 487
Á¶Èï·¡, Áø±¹¹ü,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶Èï·¡ (  ) 
¿ø±¤´ëÇб³

Áø±¹¹ü (  ) 
¿ø±¤´ëÇб³

Abstract


Determination of urinary marker proteins was carried out, trying to evaluate renal tubular damage as a part of renal injury caused by ESWL via EDAP LT-01+lithotriptor. All of twenty patients undergoing ESWL, suffered from unilateral,
nonobstructive,
infection-free, and previously untreated renal stone(s). Two urinary marker proteins, N-acetyl-beta-glucosaminidase(NAG) and beta 2-microglobulin (¥â2-M) were monitored in all the patients 1 day before, 1 and 3day(s) after ESWL using total 100
storage
of 3 sessions which is average therapeutical dose. Urinary level of NAG (normal value; 0.29-7.23 U/L) was 1.66¡¾1.31 1 day before. 1.97¡¾1.57, 2.66¡¾2.90 U/L 1 and 3 day (s) after ESWL respectively. ¥â2-M level (normal value<300 ug/L) was
142¡¾137
1 day
before, 133¡¾100, 151¡¾186 ug/L 1 and 3 day (s) after FSWL, respectively. Consequently it was concluded that ESWL using average therapeutical dose (100 stage) via EDAP LT-01+lithotriptor can hardly develop renal tubular damage.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS